{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:07:16Z","timestamp":1793995636413,"version":"4.8.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"none"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12016-021-08896-9","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T19:36:51Z","timestamp":1630697811000},"page":"377-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Challenge of Nail Psoriasis: An Update Review"],"prefix":"10.1007","volume":"61","author":[{"given":"Chao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-1668","authenticated-orcid":false,"given":"Bo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"8896_CR1","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2147\/dddt.S136986","volume":"11","author":"A Ventura","year":"2017","unstructured":"Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E (2017) New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Des Dev Ther 11:2527\u20132535. https:\/\/doi.org\/10.2147\/dddt.S136986","journal-title":"Drug design, development and therapy"},{"issue":"1","key":"8896_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12895-020-00099-7","volume":"20","author":"A Egeberg","year":"2020","unstructured":"Egeberg A, See K, Garrelts A, Burge R (2020) Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort. BMC Dermatology 20(1):3. https:\/\/doi.org\/10.1186\/s12895-020-00099-7","journal-title":"BMC dermatology"},{"issue":"5","key":"8896_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/jdv.13979","volume":"31","author":"F Bardazzi","year":"2017","unstructured":"Bardazzi F, Lambertini M, Chessa MA, Magnano M, Patrizi A, Piraccini BM (2017) Nail involvement as a negative prognostic factor in biological therapy for psoriasis: a retrospective study. J Eur Acad Dermatol Venereol 31(5):843\u2013846. https:\/\/doi.org\/10.1111\/jdv.13979","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"8896_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000246274","volume":"193","author":"EM de Jong","year":"1996","unstructured":"de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC (1996) Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology (Basel, Switzerland) 193(4):300\u2013303. https:\/\/doi.org\/10.1159\/000246274","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"8896_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000495291","volume":"235","author":"F Benhadou","year":"2019","unstructured":"Benhadou F, Mintoff D, Del Marmol V (2019) Psoriasis: keratinocytes or immune cells - which is the trigger? Dermatology (Basel, Switzerland) 235(2):91\u2013100. https:\/\/doi.org\/10.1159\/000495291","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"8896_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.det.2018.11.001","volume":"37","author":"S von Csiky-Sessoms","year":"2019","unstructured":"von Csiky-Sessoms S, Lebwohl M (2019) What\u2019s New in Psoriasis. Dermatol Clin 37(2):129\u2013136. https:\/\/doi.org\/10.1016\/j.det.2018.11.001","journal-title":"Dermatologic clinics"},{"issue":"10136","key":"8896_CR7","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/s0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273\u20132284. https:\/\/doi.org\/10.1016\/s0140-6736(18)30830-4","journal-title":"Lancet"},{"issue":"4","key":"8896_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2340\/00015555-0253","volume":"87","author":"X Fan","year":"2007","unstructured":"Fan X, Yang S, Sun LD, Liang YH, Gao M, Zhang KY, Huang W, Zhang X (2007) Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol 87(4):335\u2013340. https:\/\/doi.org\/10.2340\/00015555-0253","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"8896_CR9","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1111\/ijd.12562","volume":"53","author":"M Taheri Sarvtin","year":"2014","unstructured":"Taheri Sarvtin M, Shokohi T, Hajheydari Z, Yazdani J, Hedayati MT (2014) Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis. Int J Dermatol 53(12):e555-560. https:\/\/doi.org\/10.1111\/ijd.12562","journal-title":"Int J Dermatol"},{"issue":"5","key":"8896_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2340\/00015555-2605","volume":"97","author":"I Saulite","year":"2017","unstructured":"Saulite I, Pilmane M, Kisis J (2017) Expression of antimicrobial peptides in nail psoriasis and normal nails. Acta Derm Venereol 97(5):644\u2013645. https:\/\/doi.org\/10.2340\/00015555-2605","journal-title":"Acta dermato-venereologica"},{"issue":"6","key":"8896_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","volume":"25","author":"L Fry","year":"2007","unstructured":"Fry L, Baker BS (2007) Triggering psoriasis: the role of infections and medications. Clin Dermatol 25(6):606\u2013615. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.015","journal-title":"Clinics in dermatology"},{"issue":"6","key":"8896_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.0022-202X.2005.23927.x","volume":"125","author":"T Ito","year":"2005","unstructured":"Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bulfone-Paus S, Takigawa M, Nickoloff BJ, Paus R (2005) Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125(6):1139\u20131148. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23927.x","journal-title":"J Invest Dermatol"},{"issue":"4","key":"8896_CR13","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1111\/jdv.13970","volume":"31","author":"I Saulite","year":"2017","unstructured":"Saulite I, Pilmane M, Guenova E, Kisis J (2017) Expression of inflammatory cytokines in psoriatic nails. J Eur Acad Dermatol Venereol 31(4):e210\u2013e212. https:\/\/doi.org\/10.1111\/jdv.13970","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8896_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2020029259","volume":"37","author":"P Nirbhavane","year":"2020","unstructured":"Nirbhavane P, Sharma G, Verma S, Jadon RS, Singh B, Katare OP (2020) Nail psoriasis treatment: insights into current progress and future trends. Crit Rev Ther Drug Carrier Syst 37(2):135\u2013159. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.2020029259","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"6","key":"8896_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","volume":"43","author":"L Williamson","year":"2004","unstructured":"Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis\u2013clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43(6):790\u2013794. https:\/\/doi.org\/10.1093\/rheumatology\/keh198","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8896_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","volume":"46","author":"AL Tan","year":"2007","unstructured":"Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonagle D (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis\u2013a high-resolution MRI and histological study. Rheumatology (Oxford) 46(2):253\u2013256. https:\/\/doi.org\/10.1093\/rheumatology\/kel214","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8896_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semarthrit.2014.05.002","volume":"44","author":"MK Sandre","year":"2014","unstructured":"Sandre MK, Rohekar S (2014) Psoriatic arthritis and nail changes: exploring the relationship. Semin Arthritis Rheum 44(2):162\u2013169. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.002","journal-title":"Seminars in arthritis and rheumatism"},{"issue":"3","key":"8896_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5114\/reum.2017.68912","volume":"55","author":"P Sobolewski","year":"2017","unstructured":"Sobolewski P, Walecka I, Dopytalska K (2017) Nail involvement in psoriatic arthritis. Reumatologia 55(3):131\u2013135. https:\/\/doi.org\/10.5114\/reum.2017.68912","journal-title":"Reumatologia"},{"issue":"1","key":"8896_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","volume":"57","author":"MM Jiaravuthisan","year":"2007","unstructured":"Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY (2007) Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 57(1):1\u201327. https:\/\/doi.org\/10.1016\/j.jaad.2005.07.073","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"8896_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.1996.tb07947.x","volume":"134","author":"D De Berker","year":"1996","unstructured":"De Berker D, Mawhinney B, Sviland L (1996) Quantification of regional matrix nail production. Br J Dermatol 134(6):1083\u20131086","journal-title":"The British journal of dermatology"},{"issue":"3","key":"8896_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1211\/0022357991772448","volume":"51","author":"Y Kobayashi","year":"1999","unstructured":"Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y (1999) Drug permeation through the three layers of the human nail plate. J Pharm Pharmacol 51(3):271\u2013278. https:\/\/doi.org\/10.1211\/0022357991772448","journal-title":"The Journal of pharmacy and pharmacology"},{"issue":"5","key":"8896_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/myc.12592","volume":"60","author":"S Baswan","year":"2017","unstructured":"Baswan S, Kasting GB, Li SK, Wickett R, Adams B, Eurich S, Schamper R (2017) Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Mycoses 60(5):284\u2013295. https:\/\/doi.org\/10.1111\/myc.12592","journal-title":"Mycoses"},{"issue":"10","key":"8896_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-4362.1983.tb02124.x","volume":"22","author":"G Achten","year":"1983","unstructured":"Achten G, Parent D (1983) The normal and pathologic nail. Int J Dermatol 22(10):556\u2013565. https:\/\/doi.org\/10.1111\/j.1365-4362.1983.tb02124.x","journal-title":"Int J Dermatol"},{"issue":"6","key":"8896_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/dad.0000000000001244","volume":"41","author":"C Perrin","year":"2019","unstructured":"Perrin C (2019) Nail anatomy, nail psoriasis, and nail extensor enthesitis theory: what is the link? Am J Dermatopathol 41(6):399\u2013409. https:\/\/doi.org\/10.1097\/dad.0000000000001244","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"8896_CR25","first-page":"1315","volume":"33","author":"R Scarpa","year":"2006","unstructured":"Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A, Span\u00f2 A, Sirignano C, Oriente A, Di Minno MN, Iervolino S, Salvatore M (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33(7):1315\u20131319","journal-title":"The Journal of rheumatology"},{"issue":"1","key":"8896_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/annrheumdis-2014-205839","volume":"74","author":"AL Tan","year":"2015","unstructured":"Tan AL, Fukuba E, Halliday NA, Tanner SF, Emery P, McGonagle D (2015) High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann Rheum Dis 74(1):185\u2013189. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205839","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"8896_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11597000-000000000-00000","volume":"13","author":"ES Tan","year":"2012","unstructured":"Tan ES, Chong WS, Tey HL (2012) Nail psoriasis: a review. Am J Clin Dermatol 13(6):375\u2013388. https:\/\/doi.org\/10.2165\/11597000-000000000-00000","journal-title":"American journal of clinical dermatology"},{"issue":"2","key":"8896_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bjd.12354","volume":"169","author":"KM Klaassen","year":"2013","unstructured":"Klaassen KM, van de Kerkhof PC, Pasch MC (2013) Nail psoriasis: a questionnaire-based survey. Br J Dermatol 169(2):314\u2013319. https:\/\/doi.org\/10.1111\/bjd.12354","journal-title":"The British journal of dermatology"},{"issue":"2","key":"8896_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaad.2013.02.009","volume":"69","author":"HM van der Velden","year":"2013","unstructured":"van der Velden HM, Klaassen KM, van de Kerkhof PC, Pasch MC (2013) Fingernail psoriasis reconsidered: a case-control study. J Am Acad Dermatol 69(2):245\u2013252. https:\/\/doi.org\/10.1016\/j.jaad.2013.02.009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"8896_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00403-012-1274-9","volume":"304","author":"P Gisondi","year":"2012","unstructured":"Gisondi P, Idolazzi L, Girolomoni G (2012) Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis. Arch Dermatol Res 304(9):727\u2013732. https:\/\/doi.org\/10.1007\/s00403-012-1274-9","journal-title":"Archives of dermatological research"},{"issue":"3","key":"8896_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000332974","volume":"223","author":"A Kyriakou","year":"2011","unstructured":"Kyriakou A, Patsatsi A, Sotiriadis D (2011) Detailed analysis of specific nail psoriasis features and their correlations with clinical parameters: a cross-sectional study. Dermatology (Basel, Switzerland) 223(3):222\u2013229. https:\/\/doi.org\/10.1159\/000332974","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"8896_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2230.2006.02305.x","volume":"32","author":"S Aktan","year":"2007","unstructured":"Aktan S, Ilknur T, Akin C, Ozkan S (2007) Interobserver reliability of the Nail Psoriasis Severity Index. Clin Exp Dermatol 32(2):141\u2013144. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02305.x","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"8896_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","volume":"7","author":"J Salomon","year":"2003","unstructured":"Salomon J, Szepietowski JC, Proniewicz A (2003) Psoriatic nails: a prospective clinical study. Journal of cutaneous medicine and surgery 7(4):317\u2013321. https:\/\/doi.org\/10.1007\/s10227-002-0143-0","journal-title":"Journal of cutaneous medicine and surgery"},{"issue":"11","key":"8896_CR34","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1468-3083.2011.04289.x","volume":"26","author":"V Brazzelli","year":"2012","unstructured":"Brazzelli V, Carugno A, Alborghetti A, Grasso V, Cananzi R, Fornara L, De Silvestri A, Borroni G (2012) Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience. J Eur Acad Dermatol Venereol 26(11):1354\u20131359. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04289.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"8896_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1468-3083.2009.03364.x","volume":"23","author":"K Reich","year":"2009","unstructured":"Reich K (2009) Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 23(Suppl 1):15\u201321. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03364.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"8896_CR36","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1111\/jdv.14141","volume":"31","author":"N Di Chiacchio","year":"2017","unstructured":"Di Chiacchio N, Andr\u00e9 J, Haneke E, Di Chiacchio NG, Fonseca Noriega L, Ocampo-Garza J (2017) Pseudo-pitting of the nail in psoriasis. J Eur Acad Dermatol Venereol 31(7):e347\u2013e348. https:\/\/doi.org\/10.1111\/jdv.14141","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"8896_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4103\/0019-5154.135470","volume":"59","author":"A Dogra","year":"2014","unstructured":"Dogra A, Arora AK (2014) Nail psoriasis: the journey so far. Indian J Dermatol 59(4):319\u2013333. https:\/\/doi.org\/10.4103\/0019-5154.135470","journal-title":"Indian journal of dermatology"},{"issue":"1\u20132","key":"8896_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000448253","volume":"2","author":"A Pe\u00f1a-Romero","year":"2016","unstructured":"Pe\u00f1a-Romero A, Toussaint-Caire S, Dom\u00ednguez-Cherit J (2016) Mottled Lunulae in Nail Psoriasis: Report of Three Cases. Skin Appendage Disord 2(1\u20132):70\u201371. https:\/\/doi.org\/10.1159\/000448253","journal-title":"Skin appendage disorders"},{"key":"8896_CR39","doi-asserted-by":"publisher","unstructured":"Radtke MA, Beikert FC, Augustin M (2013) Nail psoriasis - a treatment challenge. J Dtsch Dermatol Ges JDDG 11(3):203\u2013219; quiz 220. https:\/\/doi.org\/10.1111\/ddg.12054","DOI":"10.1111\/ddg.12054"},{"issue":"6","key":"8896_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2340\/00015555-3098","volume":"99","author":"F Bardazzi","year":"2019","unstructured":"Bardazzi F, Starace M, Bruni F, Magnano M, Piraccini BM, Alessandrini A (2019) Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments. Including Biologics. Acta Derm Venereol 99(6):516\u2013523. https:\/\/doi.org\/10.2340\/00015555-3098","journal-title":"Including Biologics. Acta dermato-venereologica"},{"issue":"2","key":"8896_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1590\/abd1806-4841.20142633","volume":"89","author":"KR Schons","year":"2014","unstructured":"Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA (2014) Nail psoriasis: a review of the literature. An Bras Dermatol 89(2):312\u2013317. https:\/\/doi.org\/10.1590\/abd1806-4841.20142633","journal-title":"Anais brasileiros de dermatologia"},{"issue":"Suppl 1","key":"8896_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","volume":"23","author":"D McGonagle","year":"2009","unstructured":"McGonagle D (2009) Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol 23(Suppl 1):9\u201313. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03363.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"8896_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.det.2006.03.014","volume":"24","author":"X Wortsman","year":"2006","unstructured":"Wortsman X, Jemec GB (2006) Ultrasound imaging of nails. Dermatol Clin 24(3):323\u2013328. https:\/\/doi.org\/10.1016\/j.det.2006.03.014","journal-title":"Dermatologic clinics"},{"key":"8896_CR44","doi-asserted-by":"publisher","first-page":"8251097","DOI":"10.1155\/2018\/8251097","volume":"2018","author":"M Krajewska-W\u0142odarczyk","year":"2018","unstructured":"Krajewska-W\u0142odarczyk M, Owczarczyk-Saczonek A, Placek W, Wojtkiewicz M, Wiktorowicz A, Wojtkiewicz J (2018) Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis. BioMed Res Int\u00a02018:8251097. https:\/\/doi.org\/10.1155\/2018\/8251097","journal-title":"BioMed research international"},{"issue":"3","key":"8896_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000343607","volume":"225","author":"SZ Aydin","year":"2012","unstructured":"Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Emery P, Wakefield RJ, Wittmann M, McGonagle D (2012) Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology (Basel, Switzerland) 225(3):231\u2013235. https:\/\/doi.org\/10.1159\/000343607","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"1","key":"8896_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/rhu.0000000000000054","volume":"20","author":"C Sandobal","year":"2014","unstructured":"Sandobal C, Carb\u00f3 E, Iribas J, Roverano S, Paira S (2014) Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 20(1):21\u201324. https:\/\/doi.org\/10.1097\/rhu.0000000000000054","journal-title":"Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases"},{"issue":"1","key":"8896_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42358-019-0081-9","volume":"59","author":"JA Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a JA, Aydin SZ, D\u2019Agostino MA (2019) The use of ultrasonography in the diagnosis of nail disease among patients with psoriasis and psoriatic arthritis: a systematic review. Adv Rheumatol (London, England) 59(1):41. https:\/\/doi.org\/10.1186\/s42358-019-0081-9","journal-title":"Advances in rheumatology (London, England)"},{"issue":"2","key":"8896_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10067-009-1292-y","volume":"29","author":"M Gutierrez","year":"2010","unstructured":"Gutierrez M, Filippucci E, De Angelis R, Filosa G, Kane D, Grassi W (2010) A sonographic spectrum of psoriatic arthritis: the five targets. Clin Rheumatol 29(2):133\u2013142. https:\/\/doi.org\/10.1007\/s10067-009-1292-y","journal-title":"Clinical rheumatology"},{"issue":"5","key":"8896_CR49","first-page":"872","volume":"35","author":"SZ Aydin","year":"2017","unstructured":"Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Wakefield R, McGonagle D (2017) Vascularity of nail bed by ultrasound to discriminate psoriasis, psoriatic arthritis and healthy controls. Clin Exp Rheumatol 35(5):872","journal-title":"Clinical and experimental rheumatology"},{"issue":"12","key":"8896_CR50","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D\u2019Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, O\u2019Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485\u20132487","journal-title":"The Journal of rheumatology"},{"issue":"3","key":"8896_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.crad.2012.07.018","volume":"68","author":"L Eder","year":"2013","unstructured":"Eder L, Barzilai M, Peled N, Gladman DD, Zisman D (2013) The use of ultrasound for the assessment of enthesitis in patients with spondyloarthritis. Clin Radiol 68(3):219\u2013223. https:\/\/doi.org\/10.1016\/j.crad.2012.07.018","journal-title":"Clinical radiology"},{"issue":"4","key":"8896_CR52","first-page":"159","volume":"27","author":"LG De Filippis","year":"2005","unstructured":"De Filippis LG, Caliri A, Lo Gullo R, Bartolone S, Miceli G, Cannav\u00f2 SP, Borgia F, Basile G, Aloisi G, Zimbaro G, Scribano E, Bagnato GF (2005) Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React 27(4):159\u2013162","journal-title":"International journal of tissue reactions"},{"issue":"1","key":"8896_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ard.2007.075101","volume":"67","author":"P Gisondi","year":"2008","unstructured":"Gisondi P, Tinazzi I, El-Dalati G, Gallo M, Biasi D, Barbara LM, Girolomoni G (2008) Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 67(1):26\u201330. https:\/\/doi.org\/10.1136\/ard.2007.075101","journal-title":"Annals of the rheumatic diseases"},{"issue":"5","key":"8896_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.semarthrit.2010.05.009","volume":"40","author":"M Gutierrez","year":"2011","unstructured":"Gutierrez M, Filippucci E, De Angelis R, Salaffi F, Filosa G, Ruta S, Bertolazzi C, Grassi W (2011) Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Sem Arthritis Rheum 40(5):407\u2013412. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.009","journal-title":"Seminars in arthritis and rheumatism"},{"issue":"10","key":"8896_CR55","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/rheumatology\/ker078","volume":"50","author":"E Naredo","year":"2011","unstructured":"Naredo E, M\u00f6ller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, Mayordomo L, Moragues C, Uson J, de Agust\u00edn JJ, Mart\u00ednez A, Rej\u00f3n E, Rodriguez A, Daud\u00e9n E (2011) High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford, England) 50(10):1838\u20131848. https:\/\/doi.org\/10.1093\/rheumatology\/ker078","journal-title":"Rheumatology (Oxford, England)"},{"issue":"3","key":"8896_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.semarthrit.2017.05.002","volume":"47","author":"ML Acosta-Felquer","year":"2017","unstructured":"Acosta-Felquer ML, Ruta S, Rosa J, Marin J, Ferreyra-Garrot L, Galimberti ML, Galimberti R, Garcia-Monaco R, Soriano ER (2017) Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory. Semin Arthritis Rheum 47(3):338\u2013342. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.002","journal-title":"Seminars in arthritis and rheumatism"},{"issue":"4","key":"8896_CR57","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000508165","volume":"6","author":"A Chauhan","year":"2020","unstructured":"Chauhan A, Singal A, Grover C, Sharma S (2020) Dermoscopic Features of Nail Psoriasis: An Observational. Analytical Study. Skin Appendage Disord 6(4):207\u2013215. https:\/\/doi.org\/10.1159\/000508165","journal-title":"Analytical Study. Skin appendage disorders"},{"issue":"6","key":"8896_CR58","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1529-8019.2012.01521.x","volume":"25","author":"BM Piraccini","year":"2012","unstructured":"Piraccini BM, Bruni F, Starace M (2012) Dermoscopy of non-skin cancer nail disorders. Dermatol Ther 25(6):594\u2013602. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01521.x","journal-title":"Dermatologic therapy"},{"issue":"3","key":"8896_CR59","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4103\/0019-5154.156377","volume":"60","author":"TA Yadav","year":"2015","unstructured":"Yadav TA, Khopkar US (2015) Dermoscopy to Detect Signs of Subclinical Nail Involvement in Chronic Plaque Psoriasis: A Study of 68 Patients. Indian J Dermatol 60(3):272\u2013275. https:\/\/doi.org\/10.4103\/0019-5154.156377","journal-title":"Indian journal of dermatology"},{"issue":"1","key":"8896_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5114\/ada.2017.65618","volume":"34","author":"A Yorulmaz","year":"2017","unstructured":"Yorulmaz A, Artuz F (2017) A study of dermoscopic features of nail psoriasis. Postepy Dermatol Alergol 34(1):28\u201335. https:\/\/doi.org\/10.5114\/ada.2017.65618","journal-title":"Postepy dermatologii i alergologii"},{"issue":"4","key":"8896_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jaad.2007.11.026","volume":"58","author":"M Iorizzo","year":"2008","unstructured":"Iorizzo M, Dahdah M, Vincenzi C, Tosti A (2008) Videodermoscopy of the hyponychium in nail bed psoriasis. J Am Acad Dermatol 58(4):714\u2013715. https:\/\/doi.org\/10.1016\/j.jaad.2007.11.026","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"8896_CR62","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/1346-8138.13438","volume":"43","author":"E Errichetti","year":"2016","unstructured":"Errichetti E, Zabotti A, Stinco G, Quartuccio L, Sacco S, De Marchi G, Piccirillo A, De Vita S (2016) Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis. J Dermatol 43(10):1217\u20131220. https:\/\/doi.org\/10.1111\/1346-8138.13438","journal-title":"The Journal of dermatology"},{"issue":"5","key":"8896_CR63","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3899\/jrheum.170962","volume":"45","author":"A Zabotti","year":"2018","unstructured":"Zabotti A, Errichetti E, Zuliani F, Quartuccio L, Sacco S, Stinco G, De Vita S (2018) Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis. J Rheumatol 45(5):648\u2013654. https:\/\/doi.org\/10.3899\/jrheum.170962","journal-title":"The Journal of rheumatology"},{"issue":"7","key":"8896_CR64","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/jdv.12330","volume":"28","author":"E Cinotti","year":"2014","unstructured":"Cinotti E, Fouilloux B, Perrot JL, Labeille B, Douchet C, Cambazard F (2014) Confocal microscopy for healthy and pathological nail. J Eur Acad Dermatol Venereol 28(7):853\u2013858. https:\/\/doi.org\/10.1111\/jdv.12330","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8896_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/idoj.IDOJ_51_19","volume":"11","author":"N Wanniang","year":"2020","unstructured":"Wanniang N, Navya A, Pai V, Ghodge R (2020) Comparative Study of Clinical and Dermoscopic Features in Nail Psoriasis. Indian Dermatol Online J 11(1):35\u201340. https:\/\/doi.org\/10.4103\/idoj.IDOJ_51_19","journal-title":"Indian dermatology online journal"},{"issue":"9","key":"8896_CR66","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1365-4362.2001.01261-4.x","volume":"40","author":"I Kaur","year":"2001","unstructured":"Kaur I, Saraswat A, Kumar B (2001) Nail changes in psoriasis: a study of 167 patients. Int J Dermatol 40(9):601\u2013603. https:\/\/doi.org\/10.1046\/j.1365-4362.2001.01261-4.x","journal-title":"Int J Dermatol"},{"issue":"4","key":"8896_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5826\/dpc.0804a06","volume":"8","author":"YJ Bhat","year":"2018","unstructured":"Bhat YJ, Mir MA, Keen A, Hassan I (2018) Onychoscopy: an observational study in 237 patients from the Kashmir Valley of North India. Dermatol Pract Concept 8(4):283\u2013291. https:\/\/doi.org\/10.5826\/dpc.0804a06","journal-title":"Dermatology practical & conceptual"},{"issue":"5 Pt 1","key":"8896_CR68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s0190-9622(86)70097-2","volume":"14","author":"R Hanno","year":"1986","unstructured":"Hanno R, Mathes BM, Krull EA (1986) Longitudinal nail biopsy in evaluation of acquired nail dystrophies. J Am Acad Dermatol 14(5 Pt 1):803\u2013809. https:\/\/doi.org\/10.1016\/s0190-9622(86)70097-2","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"8896_CR69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/myc.12542","volume":"60","author":"D Rigopoulos","year":"2017","unstructured":"Rigopoulos D, Papanagiotou V, Daniel R 3rd, Piraccini BM (2017) Onychomycosis in patients with nail psoriasis: a point to point discussion. Mycoses 60(1):6\u201310. https:\/\/doi.org\/10.1111\/myc.12542","journal-title":"Mycoses"},{"issue":"2","key":"8896_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1439-0507.2011.02053.x","volume":"55","author":"L Zisova","year":"2012","unstructured":"Zisova L, Valtchev V, Sotiriou E, Gospodinov D, Mateev G (2012) Onychomycosis in patients with psoriasis\u2013a multicentre study. Mycoses 55(2):143\u2013147. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02053.x","journal-title":"Mycoses"},{"issue":"5","key":"8896_CR71","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jdv.12862","volume":"29","author":"N Zaias","year":"2015","unstructured":"Zaias N, Escovar SX, Zaiac MN (2015) Finger and toenail onycholysis. J Eur Acad Dermatol Venereol 29(5):848\u2013853. https:\/\/doi.org\/10.1111\/jdv.12862","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"8896_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000018281","volume":"199","author":"EM de Jong","year":"1999","unstructured":"de Jong EM, Menke HE, van Praag MC, van De Kerkhof PC (1999) Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology (Basel, Switzerland) 199(4):313\u2013318. https:\/\/doi.org\/10.1159\/000018281","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"3","key":"8896_CR73","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1046\/j.1365-2133.2003.05725.x","volume":"150","author":"RL Baran","year":"2004","unstructured":"Baran RL (2004) A nail psoriasis severity index. Br J Dermatol 150(3):568\u2013569. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05725.x","journal-title":"The British journal of dermatology"},{"issue":"2","key":"8896_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000068469","volume":"206","author":"SP Cannav\u00f2","year":"2003","unstructured":"Cannav\u00f2 SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B (2003) Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology (Basel, Switzerland) 206(2):153\u2013156. https:\/\/doi.org\/10.1159\/000068469","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"6","key":"8896_CR75","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2014.02.010","volume":"70","author":"KM Klaassen","year":"2014","unstructured":"Klaassen KM, van de Kerkhof PC, Bastiaens MT, Plusj\u00e9 LG, Baran RL, Pasch MC (2014) Scoring nail psoriasis. J Am Acad Dermatol 70(6):1061\u20131066. https:\/\/doi.org\/10.1016\/j.jaad.2014.02.010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"8896_CR76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","volume":"81","author":"D Rigopoulos","year":"2019","unstructured":"Rigopoulos D, Baran R, Chiheb S, Daniel CR 3rd, Di Chiacchio N, Gregoriou S, Grover C, Haneke E, Iorizzo M, Pasch M, Piraccini BM, Rich P, Richert B, Rompoti N, Rubin AI, Singal A, Starace M, Tosti A, Triantafyllopoulou I, Zaiac M (2019) Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus. J Am Acad Dermatol 81(1):228\u2013240. https:\/\/doi.org\/10.1016\/j.jaad.2019.01.072","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"8896_CR77","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1067\/s0190-9622(03)00910-1","volume":"49","author":"P Rich","year":"2003","unstructured":"Rich P, Scher RK (2003) Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 49(2):206\u2013212. https:\/\/doi.org\/10.1067\/s0190-9622(03)00910-1","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"8896_CR78","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2013.06.051","volume":"69","author":"A Garzitto","year":"2013","unstructured":"Garzitto A, Ricceri F, Tripo L, Pescitelli L, Prignano F (2013) Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score. J Am Acad Dermatol 69(6):1053\u20131054. https:\/\/doi.org\/10.1016\/j.jaad.2013.06.051","journal-title":"Journal of the American Academy of Dermatology"},{"key":"8896_CR79","doi-asserted-by":"publisher","unstructured":"Parrish CA, Sobera JO, Elewski BE (2005) Modification of the Nail Psoriasis Severity Index. J Am Acad Dermatol 53(4):745\u2013746; author reply 746\u2013747. https:\/\/doi.org\/10.1016\/j.jaad.2004.11.044","DOI":"10.1016\/j.jaad.2004.11.044"},{"issue":"6","key":"8896_CR80","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s40265-016-0564-5","volume":"76","author":"MC Pasch","year":"2016","unstructured":"Pasch MC (2016) Nail Psoriasis: A Review of Treatment Options. Drugs 76(6):675\u2013705. https:\/\/doi.org\/10.1007\/s40265-016-0564-5","journal-title":"Drugs"},{"issue":"3","key":"8896_CR81","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bjd.12664","volume":"170","author":"M Augustin","year":"2014","unstructured":"Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K (2014) Nail assessment in psoriasis and psoriatic arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 170(3):591\u2013598. https:\/\/doi.org\/10.1111\/bjd.12664","journal-title":"The British journal of dermatology"},{"issue":"1","key":"8896_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2009.03344.x","volume":"24","author":"JP Ortonne","year":"2010","unstructured":"Ortonne JP, Baran R, Corvest M, Schmitt C, Voisard JJ, Taieb C (2010) Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol 24(1):22\u201327. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03344.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"8896_CR83","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.clindermatol.2007.10.026","volume":"26","author":"G Wozel","year":"2008","unstructured":"Wozel G (2008) Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol 26(5):448\u2013459. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.10.026","journal-title":"Clinics in dermatology"},{"issue":"6","key":"8896_CR84","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1529-8019.2012.01516.x","volume":"25","author":"L Dehesa","year":"2012","unstructured":"Dehesa L, Tosti A (2012) Treatment of inflammatory nail disorders. Dermatol Ther 25(6):525\u2013534. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01516.x","journal-title":"Dermatologic therapy"},{"issue":"3","key":"8896_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/09546639909056030","volume":"10","author":"R Baran","year":"1999","unstructured":"Baran R, Tosti A (1999) Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation. J Dermatol Treat 10(3):201\u2013204. https:\/\/doi.org\/10.3109\/09546639909056030","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"8896_CR86","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1468-3083.2005.01253.x","volume":"19","author":"M S\u00e1nchez Rega\u00f1a","year":"2005","unstructured":"S\u00e1nchez Rega\u00f1a M, Mart\u00edn Ezquerra G, Umbert Millet P, Llamb\u00ed Mateos F (2005) Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. J Eur Acad Dermatol Venereol 19(5):573\u2013577. https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01253.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"8896_CR87","first-page":"912","volume":"13","author":"L Kole","year":"2014","unstructured":"Kole L, Cantrell W, Elewski B (2014) A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg\/g ointment) when compared to betamethasone diproprionate ointment (64 mg\/g) in patients with nail psoriasis. J Drugs Dermatol JDD 13(8):912\u2013915","journal-title":"Journal of drugs in dermatology : JDD"},{"issue":"4","key":"8896_CR88","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","volume":"139","author":"A Tosti","year":"1998","unstructured":"Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, Benelli C (1998) Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 139(4):655\u2013659. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02462.x","journal-title":"The British journal of dermatology"},{"key":"8896_CR89","doi-asserted-by":"publisher","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A (2007) Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study. Acta Derm Venereol 87 (2):167\u2013168. https:\/\/doi.org\/10.2340\/00015555-0195","DOI":"10.2340\/00015555-0195"},{"issue":"1","key":"8896_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000323004","volume":"222","author":"H Sar\u0131caoglu","year":"2011","unstructured":"Sar\u0131caoglu H, Oz A, Turan H (2011) Nail psoriasis successfully treated with intralesional methotrexate: case report. Dermatology (Basel, Switzerland) 222(1):5\u20137. https:\/\/doi.org\/10.1159\/000323004","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"3","key":"8896_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2340\/00015555-0401","volume":"88","author":"TY Tzung","year":"2008","unstructured":"Tzung TY, Chen CY, Yang CY, Lo PY, Chen YH (2008) Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis. Acta Derm Venereol 88(3):279\u2013280. https:\/\/doi.org\/10.2340\/00015555-0401","journal-title":"Acta dermato-venereologica"},{"issue":"4","key":"8896_CR92","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000202179","volume":"218","author":"D Rigopoulos","year":"2009","unstructured":"Rigopoulos D, Gregoriou S, Daniel Iii CR, Belyayeva H, Larios G, Verra P, Stamou C, Kontochristopoulos G, Avgerinou G, Katsambas A (2009) Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment. Dermatology (Basel, Switzerland) 218(4):338\u2013341. https:\/\/doi.org\/10.1159\/000202179","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"8896_CR93","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/00015550252948220","volume":"82","author":"D Rigopoulos","year":"2002","unstructured":"Rigopoulos D, Ioannides D, Prastitis N, Katsambas A (2002) Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm Venereol 82(2):140. https:\/\/doi.org\/10.1080\/00015550252948220","journal-title":"Acta dermato-venereologica"},{"issue":"8","key":"8896_CR94","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1468-3083.2008.02679.x","volume":"22","author":"M S\u00e1nchez Rega\u00f1a","year":"2008","unstructured":"S\u00e1nchez Rega\u00f1a M, M\u00e1rquez Balb\u00e1s G, Umbert Millet P (2008) Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. J Eur Acad Dermatol Venereol 22(8):963\u2013969. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02679.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"8896_CR95","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/0378-6323.174389","volume":"82","author":"ES Tan","year":"2016","unstructured":"Tan ES, Oon HH (2016) Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel. Indian J Dermatol Venereol Leprol 82(3):345\u2013347. https:\/\/doi.org\/10.4103\/0378-6323.174389","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"19","key":"8896_CR96","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama 323(19):1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"Jama"},{"issue":"5","key":"8896_CR97","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2230.2006.02167.x","volume":"31","author":"N Usmani","year":"2006","unstructured":"Usmani N, Wilson C (2006) A case of nail psoriasis treated with topical calcitriol. Clin Exp Dermatol 31(5):712\u2013713. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02167.x","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"8896_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5070\/D31T20Z9WW","volume":"11","author":"M Zakeri","year":"2005","unstructured":"Zakeri M, Valikhani M, Mortazavi H, Barzegari M (2005) Topical calcipotriol therapy in nail psoriasis: a study of 24 cases. Dermatol Online J 11(3):5","journal-title":"Dermatology online journal"},{"issue":"5","key":"8896_CR99","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/09546630902787585","volume":"20","author":"G M\u00e1rquez Balb\u00e1s","year":"2009","unstructured":"Balb\u00e1s GM, Rega\u00f1a MS, Millet PU (2009) Tacalcitol ointment for the treatment of nail psoriasis. J Dermatol Treat 20(5):308\u2013310. https:\/\/doi.org\/10.1080\/09546630902787585","journal-title":"The Journal of dermatological treatment"},{"issue":"2","key":"8896_CR100","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000248005","volume":"180","author":"A Tosti","year":"1990","unstructured":"Tosti A, Guerra L, Bardazzi F, Lanzarini M (1990) Topical ciclosporin in nail psoriasis. Dermatologica 180(2):110. https:\/\/doi.org\/10.1159\/000248005","journal-title":"Dermatologica"},{"key":"8896_CR101","doi-asserted-by":"publisher","unstructured":"De Simone C, Maiorino A, Tassone F, D'Agostino M, Caldarola G (2013) Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. J Eur Acad Dermatol Venereol 27(8):1003\u20131006. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04642.x","DOI":"10.1111\/j.1468-3083.2012.04642.x"},{"issue":"4","key":"8896_CR102","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000210782","volume":"1","author":"RC Hermann","year":"1988","unstructured":"Hermann RC, Taylor RS, Ellis CN, Williams NA, Weiner ND, Flynn GL, Annesley TM, Voorhees JJ (1988) Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study. Skin Pharmacol Official J Skin Pharmacol Soc 1(4):246\u2013249. https:\/\/doi.org\/10.1159\/000210782","journal-title":"Skin pharmacology : the official journal of the Skin Pharmacology Society"},{"issue":"4","key":"8896_CR103","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000107635","volume":"215","author":"AM Prins","year":"2007","unstructured":"Prins AM, Vos K, Franssen EJ (2007) Instability of topical ciclosporin emulsion for nail psoriasis. Dermatology (Basel, Switzerland) 215(4):362\u2013363. https:\/\/doi.org\/10.1159\/000107635","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"1","key":"8896_CR104","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2310\/7750.2013.13059","volume":"18","author":"C Wang","year":"2014","unstructured":"Wang C, Lin A (2014) Efficacy of topical calcineurin inhibitors in psoriasis. J Cutan Med Surg 18(1):8\u201314. https:\/\/doi.org\/10.2310\/7750.2013.13059","journal-title":"Journal of cutaneous medicine and surgery"},{"issue":"9","key":"8896_CR105","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/s0161-6420(98)99043-1","volume":"105","author":"M Hingorani","year":"1998","unstructured":"Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S (1998) A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology 105(9):1715\u20131720. https:\/\/doi.org\/10.1016\/s0161-6420(98)99043-1","journal-title":"Ophthalmology"},{"key":"8896_CR106","unstructured":"Cassell S, Kavanaugh AF (2006) Therapies for psoriatic nail disease. A systematic review. J Rheumatol 33(7):1452\u20131456"},{"key":"8896_CR107","doi-asserted-by":"publisher","unstructured":"Fischer-Levancini C, S\u00e1nchez-Rega\u00f1a M, Llamb\u00ed F, Collgros H, Exp\u00f3sito-Serrano V, Umbert-Millet P (2012) Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment. Actas Dermosifiliogr 103(8):725\u2013728. https:\/\/doi.org\/10.1016\/j.ad.2012.04.008","DOI":"10.1016\/j.ad.2012.04.008"},{"key":"8896_CR108","unstructured":"Scher RK, Stiller M, Zhu YI (2001) Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis 68 (5):355\u2013358"},{"key":"8896_CR109","doi-asserted-by":"publisher","unstructured":"Bianchi L, Soda R, Diluvio L, Chimenti S (2003) Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br J Dermatol 149(1):207\u2013209. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05392.x","DOI":"10.1046\/j.1365-2133.2003.05392.x"},{"issue":"2","key":"8896_CR110","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/lsm.22122","volume":"45","author":"YC Huang","year":"2013","unstructured":"Huang YC, Chou CL, Chiang YY (2013) Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study. Lasers Surg Med 45(2):102\u2013107. https:\/\/doi.org\/10.1002\/lsm.22122","journal-title":"Lasers in surgery and medicine"},{"issue":"2","key":"8896_CR111","first-page":"78","volume":"18","author":"K Saleem","year":"2008","unstructured":"Saleem K, Azim W (2008) Treatment of nail psoriasis with a modified regimen of steroid injections. J Coll Physicians Surg Pak\u202fJCPSP 18(2):78\u201381","journal-title":"Journal of the College of Physicians and Surgeons-Pakistan : JCPSP"},{"key":"8896_CR112","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4274\/atfm.43534","volume":"71","author":"P \u00dcst\u00fcner","year":"2018","unstructured":"\u00dcst\u00fcner P, Balevi A, \u00d6zdemir M (2018) The Comparison of the Efficacy and Safety of Intralesional Triamcinolone Acetonide and Methotrexate Injections for the Treatment of Fingernail Psoriasis. J Ankara Univ Fac Med 71:145\u2013151. https:\/\/doi.org\/10.4274\/atfm.43534","journal-title":"Journal of Ankara University Faculty of Medicine"},{"issue":"1","key":"8896_CR113","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/ijdvl.IJDVL_632_18","volume":"85","author":"S Ravindran","year":"2019","unstructured":"Ravindran S, Criton S (2019) Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine. Indian J Dermatol Venereol Leprol 85(1):81\u201382. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_632_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"8896_CR114","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1111\/j.1365-4632.2012.05611.x","volume":"53","author":"VN Sehgal","year":"2014","unstructured":"Sehgal VN, Verma P, Khurana A (2014) Anthralin\/dithranol in dermatology. Int J Dermatol 53(10):e449-460. https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05611.x","journal-title":"Int J Dermatol"},{"issue":"4","key":"8896_CR115","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1346-8138.1998.tb02386.x","volume":"25","author":"T Yamamoto","year":"1998","unstructured":"Yamamoto T, Katayama I, Nishioka K (1998) Topical anthralin therapy for refractory nail psoriasis. J Dermatol 25(4):231\u2013233. https:\/\/doi.org\/10.1111\/j.1346-8138.1998.tb02386.x","journal-title":"The Journal of dermatology"},{"issue":"5","key":"8896_CR116","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/archderm.1974.01630110033006","volume":"110","author":"T Fredriksson","year":"1974","unstructured":"Fredriksson T (1974) Topically applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol 110(5):735\u2013736","journal-title":"Archives of dermatology"},{"issue":"12","key":"8896_CR117","first-page":"1083","volume":"64","author":"K Fritz","year":"1989","unstructured":"Fritz K (1989) Successful local treatment of nail psoriasis with 5-fluorouracil. Zeitschrift fur Hautkrankheiten 64(12):1083\u20131088","journal-title":"Zeitschrift fur Hautkrankheiten"},{"key":"8896_CR118","doi-asserted-by":"publisher","unstructured":"Lassus A (1997) Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study. J Int Med Res 25(4):206\u2013209. https:\/\/doi.org\/10.1177\/030006059702500406","DOI":"10.1177\/030006059702500406"},{"issue":"11","key":"8896_CR119","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/archderm.144.11.1457","volume":"144","author":"YK Lin","year":"2008","unstructured":"Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH (2008) Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol 144(11):1457\u20131464. https:\/\/doi.org\/10.1001\/archderm.144.11.1457","journal-title":"Archives of dermatology"},{"issue":"3","key":"8896_CR120","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000333362","volume":"223","author":"YK Lin","year":"2011","unstructured":"Lin YK, See LC, Chang YC, Huang YH, Chen JL, Tsou TC, Leu YL, Shen YM (2011) Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study. Dermatology (Basel, Switzerland) 223(3):239\u2013243. https:\/\/doi.org\/10.1159\/000333362","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"6","key":"8896_CR121","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamadermatol.2014.5460","volume":"151","author":"YK Lin","year":"2015","unstructured":"Lin YK, Chang YC, Hui RC, See LC, Chang CJ, Yang CH, Huang YH (2015) A Chinese herb, indigo naturalis, extracted in oil (lindioil) used topically to treat psoriatic nails: a randomized clinical trial. JAMA Dermatol 151(6):672\u2013674. https:\/\/doi.org\/10.1001\/jamadermatol.2014.5460","journal-title":"JAMA dermatology"},{"issue":"7","key":"8896_CR122","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.phymed.2014.02.013","volume":"21","author":"YK Lin","year":"2014","unstructured":"Lin YK, See LC, Huang YH, Chang YC, Tsou TC, Lin TY, Lin NL (2014) Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial. Phytomed Int J Phytother Phytopharmacol 21(7):1015\u20131020. https:\/\/doi.org\/10.1016\/j.phymed.2014.02.013","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"issue":"7","key":"8896_CR123","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1468-3083.2009.03209.x","volume":"23","author":"F Cantoresi","year":"2009","unstructured":"Cantoresi F, Sorgi P, Arcese A, Bidoli A, Bruni F, Carnevale C, Calvieri S (2009) Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer. J Eur Acad Dermatol Venereol 23(7):832\u2013834. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03209.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8896_CR124","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/ccid.S61659","volume":"7","author":"F Cantoresi","year":"2014","unstructured":"Cantoresi F, Caserini M, Bidoli A, Maggio F, Marino R, Carnevale C, Sorgi P, Palmieri R (2014) Randomized controlled trial of a water-soluble nail lacquer based on hydroxypropyl-chitosan (HPCH), in the management of nail psoriasis. Clin Cosmet Investig Dermatol 7:185\u2013190. https:\/\/doi.org\/10.2147\/ccid.S61659","journal-title":"Clinical, cosmetic and investigational dermatology"},{"issue":"2\u20133","key":"8896_CR125","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000478257","volume":"233","author":"BM Piraccini","year":"2017","unstructured":"Piraccini BM, Starace M, Toft A (2017) Early visible improvements during K101\u201303 treatment: an open-label multicenter clinical investigation in patients with onychomycosis and\/or nail psoriasis. Dermatology (Basel, Switzerland) 233(2\u20133):178\u2013183. https:\/\/doi.org\/10.1159\/000478257","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"6","key":"8896_CR126","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1365-2133.2009.09212.x","volume":"161","author":"MM Kleinpenning","year":"2009","unstructured":"Kleinpenning MM, Smits T, Boezeman J, van de Kerkhof PC, Evers AW, Gerritsen MJ (2009) Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol 161(6):1351\u20131356. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09212.x","journal-title":"The British journal of dermatology"},{"issue":"5","key":"8896_CR127","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jaad.2011.12.015","volume":"66","author":"C Treewittayapoom","year":"2012","unstructured":"Treewittayapoom C, Singvahanont P, Chanprapaph K, Haneke E (2012) The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: a randomized, double-blind, intrapatient left-to-right study. J Am Acad Dermatol 66(5):807\u2013812. https:\/\/doi.org\/10.1016\/j.jaad.2011.12.015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"8896_CR128","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1468-3083.2010.03938.x","volume":"25","author":"M S\u00e1nchez-Rega\u00f1a","year":"2011","unstructured":"S\u00e1nchez-Rega\u00f1a M, Sola-Ortigosa J, Alsina-Gibert M, Vidal-Fern\u00e1ndez M, Umbert-Millet P (2011) Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy). J Eur Acad Dermatol Venereol 25(5):579\u2013586. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03938.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8896_CR129","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","volume":"32","author":"G Mahrle","year":"1995","unstructured":"Mahrle G, Schulze HJ, F\u00e4rber L, Weidinger G, Steigleder GK (1995) Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 32(1):78\u201388. https:\/\/doi.org\/10.1016\/0190-9622(95)90189-2","journal-title":"Journal of the American Academy of Dermatology"},{"key":"8896_CR130","doi-asserted-by":"publisher","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 61(3):451\u2013485. https:\/\/doi.org\/10.1016\/j.jaad.2009.03.027","DOI":"10.1016\/j.jaad.2009.03.027"},{"issue":"3","key":"8896_CR131","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/archdermatol.2008.600","volume":"145","author":"A Tosti","year":"2009","unstructured":"Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM (2009) Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 145(3):269\u2013271. https:\/\/doi.org\/10.1001\/archdermatol.2008.600","journal-title":"Archives of dermatology"},{"issue":"2","key":"8896_CR132","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1517\/14728214.2015.1010509","volume":"20","author":"T Mahmood","year":"2015","unstructured":"Mahmood T, Zaghi D, Menter A (2015) Emerging oral drugs for psoriasis. Expert Opin Emerg Drugs 20(2):209\u2013220. https:\/\/doi.org\/10.1517\/14728214.2015.1010509","journal-title":"Expert opinion on emerging drugs"},{"issue":"9","key":"8896_CR133","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","volume":"25","author":"M G\u00fcm\u00fc\u015fel","year":"2011","unstructured":"G\u00fcm\u00fc\u015fel M, \u00d6zdemir M, Mevlito\u011flu I, Bodur S (2011) Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol 25(9):1080\u20131084. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03927.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"17","key":"8896_CR134","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","volume":"365","author":"K Reich","year":"2011","unstructured":"Reich K, Langley RG, Papp KA, Ortonne JP, Unnebrink K, Kaul M, Valdes JM (2011) A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med 365(17):1586\u20131596. https:\/\/doi.org\/10.1056\/NEJMoa1010858","journal-title":"N Engl J Med"},{"issue":"1","key":"8896_CR135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2340\/00015555-2081","volume":"96","author":"SP Menting","year":"2016","unstructured":"Menting SP, Dekker PM, Limpens J, Hooft L, Spuls PI (2016) Methotrexate dosing regimen for plaque-type psoriasis: a systematic review of the use of test-dose, start-dose, dosing scheme, dose adjustments, maximum dose and folic acid supplementation. Acta Derm Venereol 96(1):23\u201328. https:\/\/doi.org\/10.2340\/00015555-2081","journal-title":"Acta dermato-venereologica"},{"issue":"2","key":"8896_CR136","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/bjd.17689","volume":"181","author":"KF Hjuler","year":"2019","unstructured":"Hjuler KF, Iversen L, Rasmussen MK, Kofoed K, Skov L, Zachariae C (2019) Localization of treatment-resistant areas in patients with psoriasis on biologics. Br J Dermatol 181(2):332\u2013337. https:\/\/doi.org\/10.1111\/bjd.17689","journal-title":"The British journal of dermatology"},{"issue":"4","key":"8896_CR137","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 80(4):1029\u20131072. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"8896_CR138","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1517\/14712598.2013.783561","volume":"13","author":"N Al-Mutairi","year":"2013","unstructured":"Al-Mutairi N, Nour T, Al-Rqobah D (2013) Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab. Expert Opin Biol Ther 13(5):625\u2013629. https:\/\/doi.org\/10.1517\/14712598.2013.783561","journal-title":"Expert opinion on biological therapy"},{"issue":"8","key":"8896_CR139","first-page":"958","volume":"15","author":"EB Dennehy","year":"2016","unstructured":"Dennehy EB, Zhang L, Amato D, Goldblum O, Rich P (2016) Ixekizumab is effective in subjects with moderate to severe plaque psoriasis with significant nail involvement: results from UNCOVER 3. J Drugs Dermatol JDD 15(8):958\u2013961","journal-title":"Journal of drugs in dermatology : JDD"},{"issue":"3","key":"8896_CR140","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jdv.14033","volume":"31","author":"P van de Kerkhof","year":"2017","unstructured":"van de Kerkhof P, Guenther L, Gottlieb AB, Sebastian M, Wu JJ, Foley P, Morita A, Goldblum O, Zhang L, Erickson J, Ball S, Rich P (2017) Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3. J Eur Acad Dermatol Venereol 31(3):477\u2013482. https:\/\/doi.org\/10.1111\/jdv.14033","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"8896_CR141","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","volume":"23","author":"TA Luger","year":"2009","unstructured":"Luger TA, Barker J, Lambert J, Yang S, Robertson D, Foehl J, Molta CT, Boggs R (2009) Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 23(8):896\u2013904. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03211.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"8896_CR142","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1346-8138.12229","volume":"40","author":"I Ozmen","year":"2013","unstructured":"Ozmen I, Erbil AH, Koc E, Tunca M (2013) Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study. J Dermatol 40(9):755\u2013756. https:\/\/doi.org\/10.1111\/1346-8138.12229","journal-title":"The Journal of dermatology"},{"key":"8896_CR143","doi-asserted-by":"publisher","unstructured":"Bardazzi F, Antonucci VA, Tengattini V, Odorici G, Balestri R, Patrizi A (2013) A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis. J Dtsch Dermatol Ges JDDG 11(11):1065\u20131070. https:\/\/doi.org\/10.1111\/ddg.12173","DOI":"10.1111\/ddg.12173"},{"issue":"5","key":"8896_CR144","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/bjd.12060","volume":"168","author":"JP Ortonne","year":"2013","unstructured":"Ortonne JP, Paul C, Berardesca E, Marino V, Gallo G, Brault Y, Germain JM (2013) A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis. Br J Dermatol 168(5):1080\u20131087. https:\/\/doi.org\/10.1111\/bjd.12060","journal-title":"The British journal of dermatology"},{"issue":"4","key":"8896_CR145","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1517\/14712598.2013.736960","volume":"13","author":"R Saraceno","year":"2013","unstructured":"Saraceno R, Pietroleonardo L, Mazzotta A, Zangrilli A, Bianchi L, Chimenti S (2013) TNF-\u03b1 antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis. Expert Opin Biol Ther 13(4):469\u2013473. https:\/\/doi.org\/10.1517\/14712598.2013.736960","journal-title":"Expert opinion on biological therapy"},{"issue":"3","key":"8896_CR146","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/09546634.2011.646939","volume":"24","author":"A Kyriakou","year":"2013","unstructured":"Kyriakou A, Patsatsi A, Sotiriadis D (2013) Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study. J Dermatol Treat 24(3):162\u2013168. https:\/\/doi.org\/10.3109\/09546634.2011.646939","journal-title":"The Journal of dermatological treatment"},{"issue":"9494","key":"8896_CR147","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/s0140-6736(05)67566-6","volume":"366","author":"K Reich","year":"2005","unstructured":"Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE (2005) Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 366(9494):1367\u20131374. https:\/\/doi.org\/10.1016\/s0140-6736(05)67566-6","journal-title":"Lancet"},{"issue":"4","key":"8896_CR148","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2004.09.012","volume":"52","author":"L Bianchi","year":"2005","unstructured":"Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S (2005) Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 52(4):736\u2013737. https:\/\/doi.org\/10.1016\/j.jaad.2004.09.012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"8896_CR149","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","volume":"159","author":"D Rigopoulos","year":"2008","unstructured":"Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, Antoniou C, Ioannides D (2008) Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 159(2):453\u2013456. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08686.x","journal-title":"The British journal of dermatology"},{"key":"8896_CR150","doi-asserted-by":"publisher","unstructured":"Fabroni C, Gori A, Troiano M, Prignano F, Lotti T (2011) Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients. J Eur Acad Dermatol Venereol 25(5):549\u2013553. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03826.x","DOI":"10.1111\/j.1468-3083.2010.03826.x"},{"issue":"2","key":"8896_CR151","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","volume":"58","author":"P Rich","year":"2008","unstructured":"Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MC, Guzzo C (2008) Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 58(2):224\u2013231. https:\/\/doi.org\/10.1016\/j.jaad.2007.07.042","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"8896_CR152","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jaad.2016.11.042","volume":"76","author":"K Reich","year":"2017","unstructured":"Reich K, Armstrong AW, Foley P, Song M, Wasfi Y, Randazzo B, Li S, Shen YK, Gordon KB (2017) Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. J Am Acad Dermatol 76(3):418\u2013431. https:\/\/doi.org\/10.1016\/j.jaad.2016.11.042","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"8896_CR153","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2016.11.041","volume":"76","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, Papp KA, Griffiths CE, Randazzo B, Wasfi Y, Shen YK, Li S, Kimball AB (2017) Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial. J Am Acad Dermatol 76(3):405\u2013417. https:\/\/doi.org\/10.1016\/j.jaad.2016.11.041","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"8896_CR154","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamadermatol.2018.0793","volume":"154","author":"P Foley","year":"2018","unstructured":"Foley P, Gordon K, Griffiths CEM, Wasfi Y, Randazzo B, Song M, Li S, Shen YK, Blauvelt A (2018) Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Dermatol 154(6):676\u2013683. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0793","journal-title":"JAMA dermatology"},{"issue":"11","key":"8896_CR155","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1111\/jdv.15793","volume":"33","author":"BE Elewski","year":"2019","unstructured":"Elewski BE, Baker CS, Crowley JJ, Poulin Y, Okun MM, Calimlim B, Geng Z, Reyes Servin O, Rich PA (2019) Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol 33(11):2168\u20132178. https:\/\/doi.org\/10.1111\/jdv.15793","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8896_CR156","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ard.2009.111856","volume":"69","author":"F Van den Bosch","year":"2010","unstructured":"Van den Bosch F, Manger B, Goupille P, McHugh N, R\u00f8devand E, Holck P, van Vollenhoven RF, Leirisalo-Repo M, Fitzgerald O, Kron M, Frank M, Kary S, Kupper H (2010) Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis 69(2):394\u2013399. https:\/\/doi.org\/10.1136\/ard.2009.111856","journal-title":"Annals of the rheumatic diseases"},{"issue":"3","key":"8896_CR157","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/ar3054","volume":"12","author":"M Rudwaleit","year":"2010","unstructured":"Rudwaleit M, Van den Bosch F, Kron M, Kary S, Kupper H (2010) Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy. Arthritis Res Ther 12(3):R117. https:\/\/doi.org\/10.1186\/ar3054","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"8896_CR158","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/09546634.2010.519376","volume":"23","author":"J Sola-Ortigosa","year":"2012","unstructured":"Sola-Ortigosa J, S\u00e1nchez-Rega\u00f1a M, Umbert-Millet P (2012) Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice. J Dermatol Treat 23(3):203\u2013207. https:\/\/doi.org\/10.3109\/09546634.2010.519376","journal-title":"The Journal of dermatological treatment"},{"issue":"4","key":"8896_CR159","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/archdermatol.2010.384","volume":"147","author":"C Leonardi","year":"2011","unstructured":"Leonardi C, Langley RG, Papp K, Tyring SK, Wasel N, Vender R, Unnebrink K, Gupta SR, Valdecantos WC, Bagel J (2011) Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial. Arch Dermatol 147(4):429\u2013436. https:\/\/doi.org\/10.1001\/archdermatol.2010.384","journal-title":"Archives of dermatology"},{"issue":"2","key":"8896_CR160","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/jdv.12553","volume":"29","author":"D Tha\u00e7i","year":"2015","unstructured":"Tha\u00e7i D, Unnebrink K, Sundaram M, Sood S, Yamaguchi Y (2015) Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study. J Eur Acad Dermatol Venereol 29(2):353\u2013360. https:\/\/doi.org\/10.1111\/jdv.12553","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"8896_CR161","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1468-3083.2009.03453.x","volume":"24","author":"D Rigopoulos","year":"2010","unstructured":"Rigopoulos D, Gregoriou S, Lazaridou E, Belyayeva E, Apalla Z, Makris M, Katsambas A, Ioannides D (2010) Treatment of nail psoriasis with adalimumab: an open label unblinded study. J Eur Acad Dermatol Venereol 24(5):530\u2013534. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03453.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"16","key":"8896_CR162","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","volume":"376","author":"KA Papp","year":"2017","unstructured":"Papp KA, Blauvelt A, Bukhalo M, Gooderham M, Krueger JG, Lacour JP, Menter A, Philipp S, Sofen H, Tyring S, Berner BR, Visvanathan S, Pamulapati C, Bennett N, Flack M, Scholl P, Padula SJ (2017) Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis. N Engl J Med 376(16):1551\u20131560. https:\/\/doi.org\/10.1056\/NEJMoa1607017","journal-title":"N Engl J Med"},{"issue":"4","key":"8896_CR163","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s13555-020-00383-x","volume":"10","author":"N Wasel","year":"2020","unstructured":"Wasel N, Tha\u00e7i D, French LE, Conrad C, Dutronc Y, Gallo G, Berggren L, Lacour JP (2020) Ixekizumab and ustekinumab efficacy in nail psoriasis in patients with moderate-to-severe psoriasis: 52-week results from a phase 3, head-to-head study (IXORA-S). Dermatol Ther 10(4):663\u2013670. https:\/\/doi.org\/10.1007\/s13555-020-00383-x","journal-title":"Dermatology and therapy"},{"issue":"3","key":"8896_CR164","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1346-8138.2011.01347.x","volume":"39","author":"A Igarashi","year":"2012","unstructured":"Igarashi A, Kato T, Kato M, Song M, Nakagawa H (2012) Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2\/3 clinical trial. J Dermatol 39(3):242\u2013252. https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01347.x","journal-title":"The Journal of dermatology"},{"issue":"2","key":"8896_CR165","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bjd.12632","volume":"170","author":"P Rich","year":"2014","unstructured":"Rich P, Bourcier M, Sofen H, Fakharzadeh S, Wasfi Y, Wang Y, Kerkmann U, Ghislain PD, Poulin Y (2014) Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. Br J Dermatol 170(2):398\u2013407. https:\/\/doi.org\/10.1111\/bjd.12632","journal-title":"The British journal of dermatology"},{"issue":"4","key":"8896_CR166","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000334482","volume":"223","author":"D Rigopoulos","year":"2011","unstructured":"Rigopoulos D, Gregoriou S, Makris M, Ioannides D (2011) Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study. Dermatology (Basel, Switzerland) 223(4):325\u2013329. https:\/\/doi.org\/10.1159\/000334482","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"8896_CR167","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/09546634.2011.607796","volume":"24","author":"A Patsatsi","year":"2013","unstructured":"Patsatsi A, Kyriakou A, Sotiriadis D (2013) Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study. J Dermatol Treat 24(2):96\u2013100. https:\/\/doi.org\/10.3109\/09546634.2011.607796","journal-title":"The Journal of dermatological treatment"},{"issue":"5","key":"8896_CR168","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjd.17351","volume":"181","author":"K Reich","year":"2019","unstructured":"Reich K, Sullivan J, Arenberger P, Mrowietz U, Jazayeri S, Augustin M, Parneix A, Regnault P, You R, Milutinovic M (2019) Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial. Br J Dermatol 181(5):954\u2013966. https:\/\/doi.org\/10.1111\/bjd.17351","journal-title":"The British journal of dermatology"},{"issue":"13","key":"8896_CR169","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366(13):1190\u20131199. https:\/\/doi.org\/10.1056\/NEJMoa1109997","journal-title":"N Engl J Med"},{"issue":"9","key":"8896_CR170","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/jdv.12996","volume":"29","author":"RG Langley","year":"2015","unstructured":"Langley RG, Rich P, Menter A, Krueger G, Goldblum O, Dutronc Y, Zhu B, Wei H, Cameron GS, Heffernan MP (2015) Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 29(9):1763\u20131770. https:\/\/doi.org\/10.1111\/jdv.12996","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"8896_CR171","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3899\/jrheum.170429","volume":"45","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde D, Gladman DD, Kishimoto M, Okada M, Rathmann SS, Moriarty SR, Shuler CL, Carlier H, Benichou O, Mease PJ (2018) Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III study (SPIRIT-P1). J Rheumatol 45(3):367\u2013377. https:\/\/doi.org\/10.3899\/jrheum.170429","journal-title":"The Journal of rheumatology"},{"issue":"10086","key":"8896_CR172","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/s0140-6736(17)31429-0","volume":"389","author":"P Nash","year":"2017","unstructured":"Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M (2017) Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. Lancet 389(10086):2317\u20132327. https:\/\/doi.org\/10.1016\/s0140-6736(17)31429-0","journal-title":"Lancet"},{"issue":"11","key":"8896_CR173","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/1346-8138.13927","volume":"44","author":"S Imafuku","year":"2017","unstructured":"Imafuku S, Torisu-Itakura H, Nishikawa A, Zhao F, Cameron GS (2017) Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1). J Dermatol 44(11):1285\u20131290. https:\/\/doi.org\/10.1111\/1346-8138.13927","journal-title":"The Journal of dermatology"},{"issue":"9","key":"8896_CR174","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/1346-8138.14504","volume":"45","author":"M Ohtsuki","year":"2018","unstructured":"Ohtsuki M, Kubo H, Morishima H, Goto R, Zheng R, Nakagawa H (2018) Guselkumab, an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study. J Dermatol 45(9):1053\u20131062. https:\/\/doi.org\/10.1111\/1346-8138.14504","journal-title":"The Journal of dermatology"},{"issue":"9843","key":"8896_CR175","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/s0140-6736(12)60642-4","volume":"380","author":"K Papp","year":"2012","unstructured":"Papp K, Cather JC, Rosoph L, Sofen H, Langley RG, Matheson RT, Hu C, Day RM (2012) Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 380(9843):738\u2013746. https:\/\/doi.org\/10.1016\/s0140-6736(12)60642-4","journal-title":"Lancet"},{"issue":"1","key":"8896_CR176","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","volume":"74","author":"P Rich","year":"2016","unstructured":"Rich P, Gooderham M, Bachelez H, Goncalves J, Day RM, Chen R, Crowley J (2016) Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). J Am Acad Dermatol 74(1):134\u2013142. https:\/\/doi.org\/10.1016\/j.jaad.2015.09.001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"8896_CR177","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/jdv.14738","volume":"32","author":"K Reich","year":"2018","unstructured":"Reich K, Gooderham M, Bewley A, Green L, Soung J, Petric R, Marcsisin J, Cirulli J, Chen R, Piguet V (2018) Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study. J Eur Acad Dermatol Venereol 32(3):397\u2013402. https:\/\/doi.org\/10.1111\/jdv.14738","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"8896_CR178","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.14018","volume":"173","author":"KA Papp","year":"2015","unstructured":"Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R (2015) Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials. Br J Dermatol 173(4):949\u2013961. https:\/\/doi.org\/10.1111\/bjd.14018","journal-title":"The British journal of dermatology"},{"issue":"11","key":"8896_CR179","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/1346-8138.13956","volume":"44","author":"M Abe","year":"2017","unstructured":"Abe M, Nishigori C, Torii H, Ihn H, Ito K, Nagaoka M, Isogawa N, Kawaguchi I, Tomochika Y, Kobayashi M, Tallman AM, Papp KA (2017) Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: subgroup analyses from a randomized, placebo-controlled phase 3 trial. J Dermatol 44(11):1228\u20131237. https:\/\/doi.org\/10.1111\/1346-8138.13956","journal-title":"The Journal of dermatology"},{"issue":"1","key":"8896_CR180","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jdermsci.2017.05.004","volume":"88","author":"J Zhang","year":"2017","unstructured":"Zhang J, Tsai TF, Lee MG, Zheng M, Wang G, Jin H, Gu J, Li R, Liu Q, Chen J, Tu C, Qi C, Zhu H, Ports WC, Crook T (2017) The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: a phase 3, randomized, double-blind, placebo-controlled study. J Dermatol Sci 88(1):36\u201345. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.05.004","journal-title":"Journal of dermatological science"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08896-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T22:14:54Z","timestamp":1640643294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08896-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":180,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8896"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08896-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"24 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}